{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:22:57Z","timestamp":1759332177371},"reference-count":48,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.cllc.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,11,14]],"date-time":"2013-11-14T07:46:18Z","timestamp":1384415178000},"page":"e13-e21","source":"Crossref","is-referenced-by-count":18,"title":["Metabolic Activity on [18F]-Fluorodeoxyglucose-Positron Emission Tomography\/Computed Tomography and Glucose Transporter-1 Expression Might Predict Clinical Outcomes in Patients With Limited Disease Small-Cell Lung Cancer Who Receive Concurrent Chemoradiation"],"prefix":"10.1016","volume":"15","author":[{"given":"Jieun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Oh","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chan Kwon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeon Shil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ie Ryung","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Woo Hee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun Kyung","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suk Hee","family":"Hong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Hoon","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Joon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Kyoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hyoung","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2013.09.005_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4065\/83.3.355","article-title":"Small cell lung cancer","volume":"83","author":"Sher","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cllc.2013.09.005_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-5002(00)00127-6","article-title":"A\u00a0systematic review of the role of etoposide and cisplatin in the chemotherapy of small cell lung cancer with methodology assessment and meta-analysis","volume":"30","author":"Mascaux","year":"2000","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib3","first-page":"CD006849","article-title":"Platinum versus non-platinum chemotherapy regimens for small cell lung cancer","volume":"4","author":"Amarasena","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.cllc.2013.09.005_bib4","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1056\/NEJM199212033272302","article-title":"A\u00a0meta-analysis of thoracic radiotherapy for small-cell lung cancer","volume":"327","author":"Pignon","year":"1992","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cllc.2013.09.005_bib5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1200\/JCO.1992.10.6.890","article-title":"Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis","volume":"10","author":"Warde","year":"1992","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib6","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1002\/1097-0142(19810401)47:7<1863::AID-CNCR2820470724>3.0.CO;2-6","article-title":"Small-cell carcinoma of the lung\u2014survival according to histologic subtype: a Veterans Administration Lung Group study","volume":"47","author":"Davis","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0169-5002(00)00105-7","article-title":"Predictive and prognostic factors in small cell lung cancer: current status","volume":"28","author":"Yip","year":"2000","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib8","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/JTO.0b013e3181b27799","article-title":"The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancer","volume":"4","author":"Valli\u00e8res","year":"2009","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(11)60165-7","article-title":"Small-cell lung cancer","volume":"378","author":"van Meerbeeck","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.cllc.2013.09.005_bib10","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1016\/S0959-8049(11)70173-3","article-title":"Small cell lung cancer: new clinical recommendations and current status of biomarker assessment","volume":"47","author":"Planchard","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib11","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1200\/JCO.2004.11.089","article-title":"Positron emission tomography in limited stage small-cell lung cancer: a prospective study","volume":"22","author":"Bradley","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib12","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrclinonc.2010.218","article-title":"PET-CT for radiotherapy treatment planning and response monitoring in solid tumors","volume":"8","author":"Bussink","year":"2011","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib13","first-page":"4S","article-title":"PET\/CT today and tomorrow","volume":"45","author":"Townsend","year":"2004","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cllc.2013.09.005_bib14","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.cllc.2013.09.005_bib15","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.lungcan.2011.01.007","article-title":"Prognostic significance of metabolic parameters measured by (18F)-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with small cell lung cancer","volume":"73","author":"Zhu","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S1470-2045(07)70244-9","article-title":"PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial","volume":"8","author":"Lordick","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib17","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1200\/JCO.2005.01.1189","article-title":"Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non\u2013small-cell lung cancer","volume":"23","author":"Hoekstra","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11307-009-0227-y","article-title":"Early assessment of therapeutic response using FDG PET in small cell lung cancer","volume":"11","author":"Yamamoto","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.cllc.2013.09.005_bib19","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1158\/1078-0432.CCR-08-2258","article-title":"High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.005_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nrc2817","article-title":"Targeting metabolic transformation for cancer therapy","volume":"10","author":"Tennant","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s10555-008-9151-x","article-title":"Imaging of tumor glucose utilization with positron emission tomography","volume":"27","author":"Buerkle","year":"2008","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.cllc.2013.09.005_bib22","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11748-010-0603-1","article-title":"Correlation between glucose transporter-1 expression and 18F-fluoro-2-deoxyglucose uptake on positron emission tomography in lung cancer","volume":"58","author":"Usuda","year":"2010","journal-title":"Gen Thorac Cardiovasc Surg"},{"key":"10.1016\/j.cllc.2013.09.005_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lungcan.2007.11.012","article-title":"Correlation between FDG uptake and glucose transporter type 1 expression in neuroendocrine tumors of the lung","volume":"61","author":"Song","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nrc2981","article-title":"Regulation of cancer cell metabolism","volume":"11","author":"Cairns","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib25","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1200\/JCO.2007.15.7693","article-title":"Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents","volume":"26","author":"Zeitlin","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib26","first-page":"9","article-title":"Glucose transporters: expression, regulation and cancer","volume":"35","author":"Medina","year":"2001","journal-title":"Biol Res"},{"key":"10.1016\/j.cllc.2013.09.005_bib27","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1200\/JCO.2010.31.6208","article-title":"Phase I study of Navitoclax (ABT-263), a novel Bcl-2 family inhibitor, in patients with small-cell lung cancer and other solid tumors","volume":"29","author":"Gandhi","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib28","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/JTO.0b013e3181dc211f","article-title":"Treatment with HIF-1alpha antagonist PX-478 inhibits progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice","volume":"5","author":"Jacoby","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib29","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00408-009-9169-z","article-title":"Hypoxia inducible factor-1alpha and vascular endothelial growth factor in biopsies of small cell lung carcinoma","volume":"187","author":"Ioannou","year":"2009","journal-title":"Lung"},{"key":"10.1016\/j.cllc.2013.09.005_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1007\/s12149-011-0478-y","article-title":"Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer","volume":"25","author":"Arslan","year":"2011","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.cllc.2013.09.005_bib31","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.lungcan.2011.03.013","article-title":"The role of positron emission tomography in management of small cell lung cancer","volume":"73","author":"Thomson","year":"2011","journal-title":"Lung cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3121\/cmr.2008.797","article-title":"Prognostic significance of 18 F-fluorodeoxyglucose\u00a0- positron emission tomography after treatment in patients with\u00a0limited stage small cell lung cancer","volume":"6","author":"Onitilo","year":"2008","journal-title":"Clin Med Res"},{"key":"10.1016\/j.cllc.2013.09.005_bib33","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00259-002-0937-8","article-title":"Prognostic value of [18F]FDG-PET imaging in\u00a0small cell lung cancer","volume":"30","author":"Pandit","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cllc.2013.09.005_bib34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.lungcan.2006.06.012","article-title":"PET\/CT imaging in response evaluation of patients with small cell lung cancer","volume":"54","author":"Fischer","year":"2006","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/nrc704","article-title":"Hypoxia\u2014a key regulatory factor in tumor growth","volume":"2","author":"Harris","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib36","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.radonc.2005.06.037","article-title":"Influence of oxygen concentration and pH\u00a0on expression of hypoxia induced genes","volume":"76","author":"S\u00f8rensen","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib37","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/bcr775","article-title":"Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?","volume":"6","author":"Gruber","year":"2004","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.005_bib38","first-page":"2911","article-title":"Expression of hypoxia-inducible factor-1\u03b1: a novel predictive and prognostic parameter in the radiotherapy of oropharyngeal cancer","volume":"61","author":"Aebersold","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.005_bib39","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1349-7006.2005.00025.x","article-title":"Expression of hypoxia-inducible factor-1alpha in esophageal squamous cell carcinoma","volume":"96","author":"Matsuyama","year":"2005","journal-title":"Cancer Sci"},{"key":"10.1016\/j.cllc.2013.09.005_bib40","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/sj.bjc.6603524","article-title":"Hypoxia-inducible factor-1alpha expression in the gastric carcinogenesis sequence and its prognostic role in gastric and gastro-oesophageal adenocarcinomas","volume":"96","author":"Griffiths","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib41","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/ijc.20052","article-title":"Hypoxia-inducible factor-1 alpha in non-small-cell lung cancer: relation to growth factor, protease and apoptosis pathways","volume":"111","author":"Swinson","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib42","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/sj.bjc.6601205","article-title":"Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis","volume":"89","author":"Koukourakis","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib43","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00432-009-0590-8","article-title":"Cancer's craving for sugar: an opportunity for clinical exploitation","volume":"135","author":"Yeluri","year":"2009","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.cllc.2013.09.005_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/sj.neo.7900133","article-title":"Coregulation of glucose uptake and vascular endothelial growth factor (VEGF) in two small-cell lung cancer (SCLC) sublines in\u00a0vivo and in\u00a0vitro","volume":"3","author":"Pedersen","year":"2001","journal-title":"Neoplasia"},{"key":"10.1016\/j.cllc.2013.09.005_bib45","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/j.ejca.2007.03.027","article-title":"The maximum uptake of (18)F-deoxyglucose on PET scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer","volume":"43","author":"van Baardwijk","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.cllc.2013.09.005_bib46","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10555-007-9055-1","article-title":"Hypoxia in cancer: significance and impact on clinical outcome","volume":"26","author":"Vaupel","year":"2007","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.cllc.2013.09.005_bib47","first-page":"6","article-title":"Expression of bcl-2 in small cell lung carcinoma cells","volume":"54","author":"Ikegaki","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2013.09.005_bib48","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1038\/sj.bjc.6605950","article-title":"Bcl-2 and \u03b21-integrin predict survival in a tissue microarray of small cell lung cancer","volume":"103","author":"Lawson","year":"2010","journal-title":"Br J Cancer"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041300226X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041300226X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T20:21:49Z","timestamp":1564690909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152573041300226X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S152573041300226X"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2013.09.005","relation":{},"ISSN":["1525-7304"],"issn-type":[{"value":"1525-7304","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]}}}